Literature DB >> 17012079

Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS.

N C Ware1, M A Wyatt, T Tugenberg.   

Abstract

Research on adherence to combination antiretroviral therapy has up to now focused largely upon problems of definition and measurement, and on the identification of barriers and supports. This paper examines the intersection between taking HAART and building a life with HIV/AIDS. Data consist of 214 qualitative interviews with 52 HIV-positive, active illegal drug users. A interpretive analysis drawing upon stigma and fear of disclosure as analytical constructs was applied to explain working tensions between efforts to develop social relationships on the one hand, and attempts to safeguard health through adherence on the other. The analysis specifies a mechanism through which stigma as a social process results in marginalization and exclusion. The hierarchical organization of multiple stigma is also noted. Loneliness and the desire for relatedness is intensified by drug use. Results suggest that persons with HIV/AIDS will not consistently subordinate other interests to prioritize adherence. Interventions aimed at supporting long-term adherence must address experienced conflicts between 'health' and 'life'.

Entities:  

Mesh:

Year:  2006        PMID: 17012079     DOI: 10.1080/09540120500330554

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  72 in total

1.  Measuring stigma in people with lung cancer: psychometric testing of the cataldo lung cancer stigma scale.

Authors:  Janine K Cataldo; Robert Slaughter; Thierry M Jahan; Voranan L Pongquan; Won Ju Hwang
Journal:  Oncol Nurs Forum       Date:  2011-01       Impact factor: 2.172

2.  Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.

Authors:  A M Kipp; P Pungrassami; P W Stewart; V Chongsuvivatwong; R P Strauss; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

Review 3.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

4.  Felt and enacted stigma among HIV/HCV-coinfected adults: the impact of stigma layering.

Authors:  Helen-Maria Lekas; Karolynn Siegel; Jason Leider
Journal:  Qual Health Res       Date:  2011-04-15

Review 5.  Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.

Authors:  Michael J Stirratt; Christopher M Gordon
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

6.  Stigma, social support, and depression among people living with HIV in Thailand.

Authors:  Li Li; Sung-Jae Lee; Panithee Thammawijaya; Chuleeporn Jiraphongsa; Mary Jane Rotheram-Borus
Journal:  AIDS Care       Date:  2009-08

7.  HIV stigma as a barrier to retention in HIV care at a general hospital in Lima, Peru: a case-control study.

Authors:  Carla Valenzuela; Cesar Ugarte-Gil; Jorge Paz; Juan Echevarria; Eduardo Gotuzzo; Sten H Vermund; Aaron M Kipp
Journal:  AIDS Behav       Date:  2015-02

8.  Monogamy on the Street: A Mixed-Methods Study of Homeless Men.

Authors:  Ryan A Brown; David P Kennedy; Joan S Tucker; Daniela Golinelli; Suzanne L Wenzel
Journal:  J Mix Methods Res       Date:  2013-10-01

9.  Fatigue and Sleep Disturbance Related to Perceived Stress in Chinese HIV-Positive Individuals: A Mixed Methods Study.

Authors:  Wei-Ti Chen; Cheng-Shi Shiu; Joyce P Yang; Shih-Yu Lee; Tony Szu-Hsien Lee; Jane M Simoni; Mei-Juan Bao; Hong-Zhou Lu
Journal:  J AIDS Clin Res       Date:  2013-06-18

10.  Stages of Adoption of "Treatment as Prevention" Among HIV-Negative Men Who Have Sex with Men Who Engage in Exchange Sex.

Authors:  Étienne Meunier; Karolynn Siegel; Anne E Sundelson; Eric W Schrimshaw
Journal:  AIDS Patient Care STDS       Date:  2020-09       Impact factor: 5.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.